Generic version of Plavix to be released

Published: 2007-02-20 07:00:00

Updated: 2007-02-20 07:00:00

Chong Kun Dang Pharmaceutical Co. said recently it received a product license from the Korea Food and Drug Administration over its Prigrel tablet (clopidogrel resignate) using a different salt from Sanifi-Aventis's Plavix (clopidogrel bisulfate).

Clopidogrel has shown to have activity with inh...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK